These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35809457)

  • 41. MRI-ARSACS: An Imaging Index for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) Identification Based on the Multicenter PROSPAX Study.
    Scaravilli A; Negroni D; Senatore C; Ugga L; Cosottini M; Ricca I; Bender B; Traschütz A; Başak AN; Vural A; van de Warrenburg BP; Durr A; La Piana R; Timmann D; ; Schüle R; Synofzik M; Santorelli FM; Cocozza S
    Mov Disord; 2024 Aug; 39(8):1343-1351. PubMed ID: 38847051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).
    Girard M; Larivière R; Parfitt DA; Deane EC; Gaudet R; Nossova N; Blondeau F; Prenosil G; Vermeulen EG; Duchen MR; Richter A; Shoubridge EA; Gehring K; McKinney RA; Brais B; Chapple JP; McPherson PS
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1661-6. PubMed ID: 22307627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two cases of early-onset autosomal recessive spastic ataxia of Charlevoix-Saguenay diagnosed in adulthood.
    Sahin T; Karaarslan FT; Yilmaz R; Tekgül Ş; Başak AN; Akbostanci MC
    Clin Neurol Neurosurg; 2021 Feb; 201():106423. PubMed ID: 33348119
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical and genetic variability among Bulgarian patients with autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Chamova T; Ivanova N; Cherninkova S; Koleva M; Zlatareva D; Bojinova V; Mihova K; Georgiev M; Ferdinandov D; Bichev S; Kaneva R; Mitev V; Jordanova A; Tournev I
    Mol Genet Genomic Med; 2024 Jul; 12(7):e2483. PubMed ID: 39044368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A human microglial cell model of autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Murtinheira F; Farsetti E; Macedo L; Boasinha AS; Rodrigues MS; Fernandes A; Herrera F
    Biochim Biophys Acta Mol Basis Dis; 2024 Dec; 1870(8):167452. PubMed ID: 39111629
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical and molecular studies in two new cases of ARSACS.
    Ricca I; Morani F; Bacci GM; Nesti C; Caputo R; Tessa A; Santorelli FM
    Neurogenetics; 2019 Mar; 20(1):45-49. PubMed ID: 30680480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebellar cognitive affective syndrome and autosomal recessive spastic ataxia of charlevoix-saguenay: a report of two male sibs.
    Verhoeven WM; Egger JI; Ahmed AI; Kremer BP; Vermeer S; van de Warrenburg BP
    Psychopathology; 2012; 45(3):193-9. PubMed ID: 22441213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autosomal recessive spastic ataxia of Charlevoix-Saguenay: compound heterozygotes for nonsense mutations of the SACS gene.
    Narayanan V; Rice SG; Olfers SS; Sivakumar K
    J Child Neurol; 2011 Dec; 26(12):1585-9. PubMed ID: 21745802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generation of a human iPSC line from a patient with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) caused by mutation in SACSIN gene.
    Arellano CM; Vilches A; Clemente E; Pascual-Pascual SI; Bolinches-Amorós A; Castro AA; Espinos C; Rodriguez ML; Jendelova P; Erceg S
    Stem Cell Res; 2018 Aug; 31():249-252. PubMed ID: 30144656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Novel Homozygous SACS Mutation Identified by Whole-Exome Sequencing in a Consanguineous Family with Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.
    Zeng H; Tang JG; Yang YF; Tan ZP; Tan JQ
    Cytogenet Genome Res; 2017; 152(1):16-21. PubMed ID: 28658676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS).
    Hendrickx N; Mentré F; Traschütz A; Gagnon C; Schüle R; ; ; Synofzik M; Comets E
    AAPS J; 2024 Apr; 26(3):57. PubMed ID: 38689016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrative Organelle-Based Functional Proteomics: In Silico Prediction of Impaired Functional Annotations in
    Morani F; Doccini S; Galatolo D; Pezzini F; Soliymani R; Simonati A; Lalowski MM; Gemignani F; Santorelli FM
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 35892334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Larivière R; Gaudet R; Gentil BJ; Girard M; Conte TC; Minotti S; Leclerc-Desaulniers K; Gehring K; McKinney RA; Shoubridge EA; McPherson PS; Durham HD; Brais B
    Hum Mol Genet; 2015 Feb; 24(3):727-39. PubMed ID: 25260547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropathy in ARSACS is demyelinating but without typical nerve enlargement in nerve ultrasound.
    Kneer K; Straub S; Wittlinger J; Stahl JH; Winter N; Timmann D; Schöls L; Synofzik M; Bender F; Grimm A
    J Neurol; 2024 May; 271(5):2494-2502. PubMed ID: 38261029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computer-based assessment of upper-limb incoordination in autosomal recessive spastic ataxia of Charlevoix-Saguenay patients: A pilot study.
    Bui HT; Audet O; Mathieu J; Gagnon C; Leone M
    J Neurol Sci; 2017 Sep; 380():68-73. PubMed ID: 28870592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New practical definitions for the diagnosis of autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Pilliod J; Moutton S; Lavie J; Maurat E; Hubert C; Bellance N; Anheim M; Forlani S; Mochel F; N'Guyen K; Thauvin-Robinet C; Verny C; Milea D; Lesca G; Koenig M; Rodriguez D; Houcinat N; Van-Gils J; Durand CM; Guichet A; Barth M; Bonneau D; Convers P; Maillart E; Guyant-Marechal L; Hannequin D; Fromager G; Afenjar A; Chantot-Bastaraud S; Valence S; Charles P; Berquin P; Rooryck C; Bouron J; Brice A; Lacombe D; Rossignol R; Stevanin G; Benard G; Burglen L; Durr A; Goizet C; Coupry I
    Ann Neurol; 2015 Dec; 78(6):871-86. PubMed ID: 26288984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Foveal hypoplasia in autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Shah CT; Ward TS; Matsumoto JA; Shildkrot Y
    J AAPOS; 2016 Feb; 20(1):81-3. PubMed ID: 26917082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ataxia of Charlevoix-Saguenay: MR and Clinical Results in Lower-Limb Musculature.
    Gazulla J; Mayayo-Sinués E; Benavente I; Modrego PJ; Berciano J
    Can J Neurol Sci; 2014 Jan; 41(1):37-41. PubMed ID: 24384335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Criscuolo C; Procaccini C; Meschini MC; Cianflone A; Carbone R; Doccini S; Devos D; Nesti C; Vuillaume I; Pellegrino M; Filla A; De Michele G; Matarese G; Santorelli FM
    J Neurol; 2015 Dec; 262(12):2755-63. PubMed ID: 26530509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short Review: Investigating ARSACS: models for understanding cerebellar degeneration.
    Artero Castro A; Machuca C; Rodriguez Jimenez FJ; Jendelova P; Erceg S
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):531-537. PubMed ID: 30636067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.